| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 9,825 | 8,838 | 9,250 | 8,701 | | Cost of Revenue | 1,118 | 1,164 | 1,278 | 1,017 | | | Gross Profit | 8,707 | 7,674 | 7,972 | 7,684 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,667 | 4,831 | 4,883 | 4,692 | | Non Recurring | (1,024) | 1,024 |
-
| 1,344 | | Others | 1,878 | (420) | 420 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,187 | 2,239 | 2,669 | 1,648 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 179 | 115 | 58 | (2,903) | | Earnings Before Interest And Taxes | 3,308 | 2,350 | 2,727 | (1,255) | | Interest Expense | 317 | 341 | 351 | 307 | | Income Before Tax | 2,991 | 2,009 | 2,376 | (1,562) | | Income Tax Expense | 1,211 | 814 | 962 | 517 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,780 | 1,195 | 1,414 | (2,079) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,780 | 1,195 | 1,414 | (2,079) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,780 | $1,195 | $1,414 | ($2,079) |
|
0.02% Nasdaq 
Income Statement
